6-01-2026, 16:00

Hummingbird Bioscience Announces First Patient Dosed in Phase I Clinical Trial of HMBD-501 in Advanced HER3-Expressing Solid Malignancies

Notified -
Globe Newswire6-01-2026, 16:00
13-05-2024, 16:30

Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024
Globe Newswire13-05-2024, 16:30